STRM.BIO
PrivateLast Round
Series 2
Jan 7, 2026
Total Funding Raised
$18.66M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
STRM.BIO is a biotechnology company that is developing a proprietary extracellular vesicle (EV) platform to deliver gene therapies directly to patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STRM.BIO Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
STRM.BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series 2 | Jan 7, 2026 | ||||
| Grant | Dec 3, 2025 | ||||
| Grant | Oct 3, 2023 | ||||
| Grant | Jul 26, 2022 | ||||
| Seed | Mar 31, 2021 |
Key People
Founding team and executive leadership
STRM.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Seed |
| The Engine | Seed |
| NIH RADx | Grant |
| Gaingels | Seed |
| Alix Ventures | Seed |
| Gates Foundation | Grant |
| Breakout Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2025
Awarded contract from ARPA-H for non-viral delivery technologies.
- Dec 1, 2025
Raised $8M in Series Seed 2 funding.
STRM.BIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about STRM.BIO's valuation, stock price, and market status.